$30 Billion Per Year US Heart Failure Market Presents Huge Opportunity for Promising Drugs Advancing with Positive Trial Results for Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL)

$CRDL Completed a $16 Million Private Placement and Closed a Financing for Gross Proceeds of $14.85 Million, Providing Cash Into Q4 2027. Late-Stage Life Sciences…
posteditor
posteditor
Articles: 21727

Other News